1 When using the Restylane Treatment Plan for the treatment of nasolabial folds with Restylane injectable gel, 94% of patients in clinical studies maintained results for up to 36 months from initial treatment when they had a follow-up treatment at 4.5 months or 9 months and 18 months. The maintenance of results using Restylane-L, Restylane Fine Lines, Perlane and Perlane-L injectable gels has not been studied. Data on file, Medicis Pharmaceutical Corporation.
The Restylane family of products includes Restylane®, Restylane-L™, Restylane Fine Lines™, Restylane Fine Lines-L™, Perlane®, and Perlane-L™. These products are used to add volume to facial tissue for the correction of wrinkles, facial contour augmentation and lip enhancement. Restylane-L, Perlane-L, and Restylane Fine Lines-L have been enhanced with the addition of lidocaine in order to reduce discomfort during treatment.
Important Safety Considerations for the Restylane Family of Products
Treatment with the Restylane family of products may pose risks and may not be suitable for everyone. You should not use the Restylane family of products if you are pregnant or breastfeeding, or if you are under 18 years of age. You should not use Restylane-L, Perlane-L, or Restylane Fine Lines-L if you have a hypersensitivity to local anesthetics of the amide type, such as lidocaine. The most common side effects of treatment are swelling, redness, pain, itching, discolouration, and tenderness at the injection site. This will typically last less than a week. Temporary lumpiness has also been observed in some patients. Like any injection in the skin, the implantation of the Restylane family of products carries a risk of infection. The Restylane family of products should only be injected by a licensed healthcare professional. Complete product and safety information is available at www.Restylane.ca.
About Medicis Aesthetics Canada
Restylane, Restylane-L, Perlane, Perlane-L and Restylane Fine Lines are trade-marks of HA North American Sales AB.All other trade-marks are the property of their respective owners.RESCA 10-090